Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (366 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 20 Feb 2025 – 20 Aug 2026, limited by HDFC Nifty100 Quality 30 Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | HDFC Nifty100 Quality 30 Index Fund | Nifty 100 |
|---|---|---|
| 20 Feb 2025 | ₹100.00 | ₹100.00 |
| 07 Apr 2025 | ₹94.59 | ₹96.87 |
| 22 May 2025 | ₹105.46 | ₹107.73 |
| 07 Jul 2025 | ₹108.77 | ₹111.38 |
| 21 Aug 2025 | ₹107.68 | ₹109.80 |
| 06 Oct 2025 | ₹107.67 | ₹109.95 |
| 20 Nov 2025 | ₹111.36 | ₹114.28 |
| 05 Jan 2026 | ₹112.83 | ₹114.72 |
| 19 Feb 2026 | ₹106.98 | ₹111.44 |
| 06 Apr 2026 | ₹99.61 | ₹100.72 |
| 21 May 2026 | ₹105.58 | ₹105.06 |
| 06 Jul 2026 | ₹106.29 | ₹108.77 |
| 20 Aug 2026 | ₹109.82 | ₹108.46 |
| Metric | HDFC · Regular NAV ₹10.98 Very High risk ★★☆☆☆ 1Y | Category median Index Funds · 366 funds |
|---|---|---|
| +1.78% | +5.43% | |
| — | +8.41% | |
| — | +8.95% | |
| — | +11.28% | |
| +6.47% | +7.40% | |
| +4.56% | — | |
| — | +11.37% | |
| — | +13.00% | |
| — | +11.07% | |
| Risk | ||
| 12.70% | 13.88% | |
| -0.37 | 0.25 | |
| -0.51 | 0.35 | |
| -15.62% | -16.66% | |
| Nifty 100 | — | |
| — | +0.30% | |
| — | 1.00 | |
| — | 101.3% | |
| — | 98.8% | |
| 0.91% | 0.96% | |
| ₹148.34Cr | ₹182.17Cr | |
| None | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 25% | 35% | |
| Arun Agarwal | — | |
| 20 Feb 2025 | — | |
| 30 | — | |
| 46.4% | — | |
| 0.6% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.